annb0t
Top 20
The last three months have been tough on Neuren Pharmaceuticals Limited (ASX:NEU) shareholders, who have seen the share price decline a rather worrying 32%. But over three years the performance has been really wonderful. Over that time, we've been excited to watch the share price climb an impressive 576%. Arguably, the recent fall is to be expected after such a strong rise. The thing to consider is whether there is still too much elation around the company's prospects. It really delights us to s...
>>> Read more: Those who invested in Neuren Pharmaceuticals (ASX:NEU) three years ago are up 576%
>>> Read more: Those who invested in Neuren Pharmaceuticals (ASX:NEU) three years ago are up 576%
